Get started
Author

Timothy Reid

Observed names: Reid, Reid, Timothy, Reid, Timothy S., T. Reid, TIMOTHY REID, TIMOTHY S. REID, Timothy S Reid, Timothy S. Reid
Institution: Mercy Health System
OpenAlex ID: A5000792801
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different
2019 · Alice Y. Y. Cheng, Dhiren K. Patel, et al. · Advances in Therapy · 51
PDF
How much is too much? Outcomes in patients using high‐dose insulin glargine
2015 · T. Reid, L. Gao, et al. · International Journal of Clinical Practice · 46
PDF
Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Primary Care
2013 · Timothy S. Reid · Clinical Diabetes · 43
Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers
2019 · Louis Kuritzky, Timothy S. Reid, et al. · Clinical Diabetes · 36
Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
2012 · Timothy Reid · Clinical Diabetes · 35
Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables
2019 · Tricia Santos Cavaiola, Yan Kiriakov, et al. · Clinical Therapeutics · 30
PDF
Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes
2014 · Charles F. Shaefer, Timothy S. Reid, et al. · Postgraduate Medicine · 18
Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes
2018 · Fang Liz Zhou, Jason Yeaw, et al. · BMJ Open Diabetes Research & Care · 16
PDF
A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes
2014 · J Hans DeVries, Luigi Meneghini, et al. · touchREVIEWS in Endocrinology · 11
PDF
Fasting Versus Postprandial Hyperglycemia as a Treatment Target to Lower Elevated Hemoglobin A1C
2015 · Charles Shaefer, Timothy Reid, et al. · Endocrine Practice · 9
Insulin for Type 2 Diabetes Mellitus: Separating the Myths from the Facts
2007 · Timothy S. Reid · Insulin · 8
Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin
2022 · Eugene E Wright, Daniel C Malone, et al. · Journal of Managed Care & Specialty Pharmacy · 7
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program
2018 · Jennifer D. Goldman, Jasvinder Gill, et al. · Diabetes Therapy · 7
PDF
Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, for the Management of Type 2 Diabetes
2014 · Stephen Brunton, Timothy S. Reid · Hospital Practice · 7
Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences
2014 · Charles Shaefer, Timothy Reid, et al. · Diabetes/Metabolism Research and Reviews · 4
The importance and treatment of postprandial hyperglycemia.
2010 · Timothy S Reid · PubMed · 4
Higher concentration insulins: an overview of clinical considerations
2017 · Timothy S. Reid, Fryn Schafer, et al. · Postgraduate Medicine · 3
A Short-Acting GLP-1 Analog or Prandial Insulin to Supplement Basal Insulin?—Moving Toward Personalized Management of Type 2 Diabetes Mellitus
2014 · Irl B. Hirsch, Doron Schneider, et al. · Postgraduate Medicine · 3
A Practice-Based Research Network Focused on Comparative Effectiveness Research in Type 2 Diabetes Management
2013 · John E. Anderson, Andrew S. Rhinehart, et al. · Postgraduate Medicine · 3
Individualizing insulin therapy.
2012 · Luigi Meneghini, Timothy Reid · PubMed · 3
Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/ mL
2018 · George Dailey, Timothy Reid, et al. · Endocrinology Diabetes & Metabolism · 2
PDF
Practical Screening for Islet Autoantibodies: The Time Has Come
2022 · Reid · The Journal of Family Practice · 1
103-LB: Real-World Persistence, Adherence, Health Care Resource Utilization, and Costs in People with Type 2 Diabetes (T2D) Switching from Basal Insulin (BI) to Second-Generation BI (Insulin Glargine 300 U/mL [Gla-300]) vs. First-Generation BI (Insulin Glargine 1
2021 · EUGENE WRIGHT, JASVINDER GILL, et al. · Diabetes
Diabetes Management Update: Individualizing Treatment.
2019 · Timothy Reid · PubMed
The Relevance of Clinical Pharmacology Studies of Basal Insulins to Primary Care.
2019 · Timothy S Reid, John White, et al. · PubMed
Works count: 37
Citation count: 347
H-index: 9
I10-index: 9
Year
Topic
Type